Svenska
Home
About
Active Biotech in Brief
Board of Directors
Management
Business Concept
Corporate Governance
Corporate Governance Report 2020
Article of Association
Audit committee
Scientific committee
Election Committee
General Meetings
Auditors
Partnerships
Career
Projects
Project Overview
Naptumomab
Tasquinimod
Laquinimod
Patents
Orphan Drug Designation
Investor
Investor
Analyses and Presentations
Analysts
Capital Markets Day 2020
Financial Calendar
Financial Reports
Interim Reports
Annual Reports
Stock
Ownership
Official Documents
Rights Issue 2014
Rights Issue 2016
Rights Issue 2018
Rights Issue 2021
Media
Press Contact
Press Releases
Subscribe
News
Image Bank
Contact
Copyright © 2021 Active Biotech AB.
All Rights Reserved.
Design by
Clavis Communications
.
Investor
Investor
Analyses and Presentations
Analysts
Capital Markets Day 2020
Financial Calendar
Financial Reports
Stock
Ownership
Official Documents
Financial Calendar
August 5, 2021, Interim report
November 4, 2021, Interim report
February 9, 2022, Year-end report 2021
This site uses cookies.
Okay, thanks
